| Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017 A Avan, H Digaleh, M Di Napoli, S Stranges, R Behrouz, ... BMC Medicine 17 (191), 2019 | 433 | 2019 |
| Platinum‐induced neurotoxicity and preventive strategies: past, present, and future A Avan, TJ Postma, C Ceresa, A Avan, G Cavaletti, E Giovannetti, ... The oncologist 20 (4), 411-432, 2015 | 259 | 2015 |
| Concomitant vascular and neurodegenerative pathologies double the risk of dementia MR Azarpazhooh, A Avan, LE Cipriano, DG Munoz, LA Sposato, ... Alzheimer's & Dementia: Journal of the Alzheimer's Association 14 (2), 148-156, 2018 | 171 | 2018 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 167 | 2022 |
| Covid-19 pandemic and burden of non-communicable diseases: An ecological study on data of 185 countries MR Azarpazhooh, N Morovatdar, A Avan, TG Phan, AA Divani, N Yassi, ... Journal of Stroke and Cerebrovascular Diseases 29 (9), 105089, 2020 | 158 | 2020 |
| Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 GBD 2019 Collaborators, E Nichols, F Abd‐Allah, A Abdoli, AE Abosetugn, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021 | 86 | 2021 |
| Role of Akt signaling in resistance to DNA-targeted therapy A Avan, R Narayan, E Giovannetti, GJ Peters World J Clin Oncol 7 (5), 352-369, 2016 | 79 | 2016 |
| Stroke and dementia, leading causes of neurological disability and death, potential for prevention A Avan, V Hachinski Alzheimer's & Dementia 17 (6), 1072-1076, 2021 | 68 | 2021 |
| Cerebral blood flow changes during aging process and in cognitive disorders: a review N Mokhber, A Shariatzadeh, A Avan, H Saber, G Shojaeian Babaei, ... Neuroradiology Journal, The, 2021 | 50 | 2021 |
| AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients A Avan, A Avan, TYS Le Large, A Mambrini, N Funel, M Maftouh, ... Plos one 9 (9), e108057, 2014 | 46 | 2014 |
| VU Research Portal A Avan | 45* | |
| Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy R Squitti, A Pal, M Picozza, A Avan, M Ventriglia, MC Rongioletti, ... Biomolecules 10 (8), 1164, 2020 | 39 | 2020 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 35 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 32 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 31 | 2024 |
| Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study A Avan, V Hachinski Alzheimer's & Dementia 19 (4), 1281-1291, 2023 | 31 | 2023 |
| Brain health: Key to health, productivity, and well-being A Avan, V Hachinski, AH Aamodt, C Alessi, S Ali, S Alladi, R Andersen, ... Alzheimer's & dementia: the journal of the Alzheimer's Association, 2021 | 31 | 2021 |
| Zinc and Copper in Alzheimer’s Disease A Avan, TU Hoogenraad Journal of Alzheimer's Disease 46 (1), 89-92, 2015 | 31 | 2015 |
| Predictive role of repair enzymes in the efficacy of Cisplatin combinations in pancreatic and lung cancer GJ Peters, A Avan, MG Ruiz, V Orsini, A Avan, E Giovannetti, EF Smit Anticancer research 34 (1), 435-442, 2014 | 31 | 2014 |
| Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B C Ceresa, A Avan, E Giovannetti, AA Geldof, A Avan, G Cavaletti, ... Anticancer research 34 (1), 517-523, 2014 | 29 | 2014 |
M. Reza AzarpazhoohAssociate Professor of Neurology, Western University,Canada在 lhsc.on.ca 的电子邮件经过验证
